Predictive Markers and Targeted Therapies in Thyroid Cancer and Selected Endocrine Tumors

Juan C. Hernandez-Prera; Bruce M. Wenig

doi:10.1007/978-3-319-95228-4_45

Predictive Markers and Targeted Therapies in Thyroid Cancer and Selected Endocrine Tumors

Juan C. Hernandez-Prera
, Bruce M. Wenig

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

Abstract

Endocrine tumors are ubiquitous and can arise in many organs such as the pituitary, the pancreas, the ovaries, the testicles, the thyroid, the parathyroid, and the adrenal glands. Many of these tumors retain the ability to secrete hormones which can be the source of their symptomatology. In this chapter, we will mainly cover biomarkers associated with thyroid cancer - the most common malignancy of the endocrine system- and briefly touch upon other tumors such as the parathyroid carcinoma and adrenal gland neoplasia.

Original language	English
Title of host publication	Predictive Biomarkers in Oncology
Subtitle of host publication	Applications in Precision Medicine
Publisher	Springer International Publishing
Pages	493-500
Number of pages	8
ISBN (Electronic)	9783319952284
ISBN (Print)	9783319952277
DOIs	https://doi.org/10.1007/978-3-319-95228-4_45
State	Published - 1 Jan 2018
Externally published	Yes

Keywords

Adrenocortical carcinoma
Follicular thyroid carcinoma
Mitogen-activated protein kinase (MAPK) signaling pathway
PI3K/Akt/mTOR signaling pathway
Papillary thyroid carcinoma
Paraganglioma
Parathyroid carcinoma
Pheochromocytoma
Tyrosine kinase inhibitors

Access to Document

10.1007/978-3-319-95228-4_45

Cite this

@inbook{a84798867afb4f7dab6c58b2aa20752e,

title = "Predictive Markers and Targeted Therapies in Thyroid Cancer and Selected Endocrine Tumors",

abstract = "Endocrine tumors are ubiquitous and can arise in many organs such as the pituitary, the pancreas, the ovaries, the testicles, the thyroid, the parathyroid, and the adrenal glands. Many of these tumors retain the ability to secrete hormones which can be the source of their symptomatology. In this chapter, we will mainly cover biomarkers associated with thyroid cancer - the most common malignancy of the endocrine system- and briefly touch upon other tumors such as the parathyroid carcinoma and adrenal gland neoplasia.",

keywords = "Adrenocortical carcinoma, Follicular thyroid carcinoma, Mitogen-activated protein kinase (MAPK) signaling pathway, PI3K/Akt/mTOR signaling pathway, Papillary thyroid carcinoma, Paraganglioma, Parathyroid carcinoma, Pheochromocytoma, Tyrosine kinase inhibitors",

author = "Hernandez-Prera, \{Juan C.\} and Wenig, \{Bruce M.\}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Switzerland AG 2019.",

year = "2018",

month = jan,

day = "1",

doi = "10.1007/978-3-319-95228-4\_45",

language = "English",

isbn = "9783319952277",

pages = "493--500",

booktitle = "Predictive Biomarkers in Oncology",

publisher = "Springer International Publishing",

}

TY - CHAP

T1 - Predictive Markers and Targeted Therapies in Thyroid Cancer and Selected Endocrine Tumors

AU - Hernandez-Prera, Juan C.

AU - Wenig, Bruce M.

N1 - Publisher Copyright: © Springer Nature Switzerland AG 2019.

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Endocrine tumors are ubiquitous and can arise in many organs such as the pituitary, the pancreas, the ovaries, the testicles, the thyroid, the parathyroid, and the adrenal glands. Many of these tumors retain the ability to secrete hormones which can be the source of their symptomatology. In this chapter, we will mainly cover biomarkers associated with thyroid cancer - the most common malignancy of the endocrine system- and briefly touch upon other tumors such as the parathyroid carcinoma and adrenal gland neoplasia.

AB - Endocrine tumors are ubiquitous and can arise in many organs such as the pituitary, the pancreas, the ovaries, the testicles, the thyroid, the parathyroid, and the adrenal glands. Many of these tumors retain the ability to secrete hormones which can be the source of their symptomatology. In this chapter, we will mainly cover biomarkers associated with thyroid cancer - the most common malignancy of the endocrine system- and briefly touch upon other tumors such as the parathyroid carcinoma and adrenal gland neoplasia.

KW - Adrenocortical carcinoma

KW - Follicular thyroid carcinoma

KW - Mitogen-activated protein kinase (MAPK) signaling pathway

KW - PI3K/Akt/mTOR signaling pathway

KW - Papillary thyroid carcinoma

KW - Paraganglioma

KW - Parathyroid carcinoma

KW - Pheochromocytoma

KW - Tyrosine kinase inhibitors

UR - https://www.scopus.com/pages/publications/85134856054

U2 - 10.1007/978-3-319-95228-4_45

DO - 10.1007/978-3-319-95228-4_45

M3 - Chapter

AN - SCOPUS:85134856054

SN - 9783319952277

SP - 493

EP - 500

BT - Predictive Biomarkers in Oncology

PB - Springer International Publishing

ER -

Predictive Markers and Targeted Therapies in Thyroid Cancer and Selected Endocrine Tumors

Abstract

Keywords

Access to Document

Fingerprint

Cite this